Indian pharma companies should shed jugaad attitude: G V Prasad, CEO (Dr Reddy’s Laboratories) – Economic Times

Dr Reddy’s Laboratories may not be making news for big pharma deals. The Hyderabad-based company remains focused on unique product launches in key markets. In the past year, the market capitalisation of Dr Reddy’s increased to about Rs 55,000 crore on the back of a 35% gain in the stock price, making it one of India’s most valuable pharmaceutical companies. In an exclusive interview to ET, Chief Executive Officer G V Prasad opens up about how “jugaad” attitude caused lapses among few Indian drug makers, leading US Food & Drug Administration to impose curbs on some plants.

Read more – Economic Times